Profile
Mr. Jason Fredette is a Vice President-Investor Relations & Communications at Intellia Therapeutics, Inc. Mr. Fredette was previously employed as a Head-Investor Relations by Axcella Health, Inc., a Vice President-Investor Relations by Epizyme, Inc., a Senior Director-Investor Relations by Chiasma, Inc., a Vice President-Communications & Marketing by American Superconductor Corp., a Head-Investor Relation Contact by Mersana Therapeutics, Inc., a Director-Investor Relations by Office Properties Income Trust, a Director-Investor Relations by REIT Management & Research LLC, a Director-Investor Relations by Select Income REIT, and a Head-Investor Relations by Selecta Biosciences, Inc.
Jason Fredette active positions
| Companies | Position | Start |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Investor Relations Contact | 01/01/2025 |
Former positions of Jason Fredette
| Companies | Position | End |
|---|---|---|
| MERSANA THERAPEUTICS | Investor Relations Contact | 06/01/2026 |
| CHIASMA, INC. | Investor Relations Contact | 01/01/2016 |
| AXCA HEALPAR | Investor Relations Contact | - |
| EPIZYME, INC. | Investor Relations Contact | - |
| CARTESIAN THERAPEUTICS, INC. | Investor Relations Contact | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
American Superconductor Corp.
American Superconductor Corp. Electrical ProductsProducer Manufacturing Provides megawatt scale solutions | Producer Manufacturing |
REIT Management & Research LLC
REIT Management & Research LLC Real Estate Investment TrustsFinance Acts as a Real Estate Investment Trust/REIT | Finance |
Chiasma, Inc.
Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Office Properties Income Trust
Office Properties Income Trust Real Estate Investment TrustsFinance Functions as a real estate investment trust which owns and leases office properties | Finance |
Select Income REIT
Select Income REIT Real Estate Investment TrustsFinance Owns and invests in net leased, single tenant properties | Finance |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Axcella Health, Inc.
Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
- Stock Market
- Insiders
- Jason Fredette
















